India Glycine: Prelim Results of AD Admin Review
The Commerce Department has published the preliminary results of its antidumping duty administrative review on glycine from India (A-533-883), calculating AD rates of zero percent for the three companies remaining under review: Avid Organics Private Limited, Kumar Industries and Bajaj Healthcare Limited. If the agency's findings are continued in the final results, importers of subject merchandise from these three companies entered June 1, 2022, through May 31, 2023, won't be assessed AD, and future entries from these three companies wouldn't be subject to AD cash deposits until further notice.
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
Commerce also said that it is rescinding this review for 27 companies that had their requests for review withdrawn. See Appendix II of the notice for a full list. Any subject merchandise entered under their AD case numbers would be liquidated at the 7.23% all-others rate.
Commerce has already ordered liquidation as entered, at the cash deposit rate in effect at the time of entry, for entries during the period of review from all exporters not under review, in a message to CBP (ADCVDWeb Message # 3257407).
(The period of review is 06/01/22 - 05/31/23. See the notice for additional information, including the scope of the order, potential cash deposit and assessment instructions, etc.)